252 related articles for article (PubMed ID: 33416106)
1. ROS‑mediated hypomethylation of PRDX5 promotes STAT3 binding and activates the Nrf2 signaling pathway in NSCLC.
Cao X; Chen XM; Xiao WZ; Li B; Zhang B; Wu Q; Xue Q
Int J Mol Med; 2021 Feb; 47(2):573-582. PubMed ID: 33416106
[TBL] [Abstract][Full Text] [Related]
2. PRDX5 as a novel binding partner in Nrf2-mediated NSCLC progression under oxidative stress.
Chen X; Cao X; Xiao W; Li B; Xue Q
Aging (Albany NY); 2020 Jan; 12(1):122-137. PubMed ID: 31899687
[TBL] [Abstract][Full Text] [Related]
3. Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.
Wu Z; Jiao M; Shu C; Zhang S; Wang J; Pu J; Zhu J; Zeng Y; Zhu Y; Liu Z
Cell Commun Signal; 2024 Jun; 22(1):313. PubMed ID: 38844957
[TBL] [Abstract][Full Text] [Related]
4. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
[TBL] [Abstract][Full Text] [Related]
5. RNF111/Arkadia is regulated by DNA methylation and affects TGF-β/Smad signaling associated invasion in NSCLC cells.
Chen H; Yang T; Lei Z; Wang L; Yang H; Tong X; Yang WT; Zhao J; Gu Y; Chen Y; Zhang HT
Lung Cancer; 2015 Oct; 90(1):32-40. PubMed ID: 26238425
[TBL] [Abstract][Full Text] [Related]
6. Raddeanin A induced apoptosis of non-small cell lung cancer cells by promoting ROS-mediated STAT3 inactivation.
Li L; Chen M; Li G; Cai R
Tissue Cell; 2021 Aug; 71():101577. PubMed ID: 34146943
[TBL] [Abstract][Full Text] [Related]
7. OGT regulated O-GlcNacylation promotes migration and invasion by activating IL-6/STAT3 signaling in NSCLC cells.
Ge X; Peng X; Li M; Ji F; Chen J; Zhang D
Pathol Res Pract; 2021 Sep; 225():153580. PubMed ID: 34391182
[TBL] [Abstract][Full Text] [Related]
8. Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer.
Xie C; Zhou X; Liang C; Li X; Ge M; Chen Y; Yin J; Zhu J; Zhong C
J Exp Clin Cancer Res; 2021 Aug; 40(1):266. PubMed ID: 34429133
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Human Papillomavirus Type 16 Oncoproteins Enhances Epithelial-Mesenchymal Transition via STAT3 Signaling Pathway in Non-Small Cell Lung Cancer Cells.
Zhang W; Wu X; Hu L; Ma Y; Xiu Z; Huang B; Feng Y; Tang X
Oncol Res; 2017 May; 25(5):843-852. PubMed ID: 28508744
[TBL] [Abstract][Full Text] [Related]
10. The synergistic effects of PRDX5 and Nrf2 on lung cancer progression and drug resistance under oxidative stress in the zebrafish models.
Qian S; Fang Y; Yao C; Wang Y; Zhang Z; Wang X; Gao J; Feng Y; Sun L; Zou R; Zhou G; Ye J; Xia R; Xia H
Oncol Res; 2022; 30(2):53-64. PubMed ID: 37305326
[TBL] [Abstract][Full Text] [Related]
11. PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer.
Lin X; Lin BW; Chen XL; Zhang BL; Xiao XJ; Shi JS; Lin JD; Chen X
Biochem Biophys Res Commun; 2017 Dec; 493(4):1464-1470. PubMed ID: 28988111
[TBL] [Abstract][Full Text] [Related]
12. miR-125a regulates HAS1 and inhibits the proliferation, invasion and metastasis by targeting STAT3 in non-small cell lung cancer cells.
Huang H; Huang J; Yao J; Li N; Yang Z
J Cell Biochem; 2020 Jun; 121(5-6):3197-3207. PubMed ID: 31930562
[TBL] [Abstract][Full Text] [Related]
13. THAP9-AS1 Promotes Tumorigenesis and Reduces ROS Generation through the JAK2/STAT3 Signaling Pathway by Increasing SOCS3 Promoter Methylation in Osteosarcoma.
Yang S; Wang B; Liu C; Wang Q; Wang R; Su W; Zhu Y; Li M; Guo Z; Wu X; Chen F
Oxid Med Cell Longev; 2021; 2021():5620475. PubMed ID: 34691358
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S‑transferase ω 1 promotes the proliferation, migration and invasion, and inhibits the apoptosis of non‑small cell lung cancer cells, via the JAK/STAT3 signaling pathway.
Wang K; Zhang FL; Jia W
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236161
[TBL] [Abstract][Full Text] [Related]
15. Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway.
Wang WP; Sun Y; Lu Q; Zhao JB; Wang XJ; Chen Z; Ni YF; Wang JZ; Han Y; Zhang ZP; Yan XL; Li XF
Oncotarget; 2017 Jan; 8(4):5909-5923. PubMed ID: 27992365
[TBL] [Abstract][Full Text] [Related]
16. Organophosphate-pesticides induced survival mechanisms and APE1-mediated Nrf2 regulation in non-small-cell lung cancer cells.
Thakur S; Sarkar B; Dhiman M; Mantha AK
J Biochem Mol Toxicol; 2021 Feb; 35(2):e22640. PubMed ID: 33078895
[TBL] [Abstract][Full Text] [Related]
17. SphK1 promotes development of non‑small cell lung cancer through activation of STAT3.
Ma Y; Xing X; Kong R; Cheng C; Li S; Yang X; Li S; Zhao F; Sun L; Cao G
Int J Mol Med; 2021 Jan; 47(1):374-386. PubMed ID: 33236138
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
[TBL] [Abstract][Full Text] [Related]
20. PTPRT epigenetic silencing defines lung cancer with STAT3 activation and can direct STAT3 targeted therapies.
Sen M; Kindsfather A; Danilova L; Zhang F; Colombo R; LaPorte MG; Kurland BF; Huryn DM; Wipf P; Herman JG
Epigenetics; 2020; 15(6-7):604-617. PubMed ID: 31595832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]